Economic development officials in Baltimore are fretting that they're one step behind the pace being set in Montgomery County, where low-cost lab space along with offers of small loans and grants have been luring away emerging drug developers. In the case of Amulet Pharmaceuticals, a spinoff of Johns Hopkins, a $25,000 loan and some free PR proved too much to ignore.
It's a big issue for Baltimore, which has two new bioparks to fill. One particularly thorny issue, according to the Baltimore Business Journal, is getting the city of Baltimore to work as a team with the county. Another key will be in coming up with competitive lease rates for developers in need of lab space.
- read the article [1] in the Baltimore Business Journal
Related Article:
Top Five Regions Targeting Biotech Companies - 2008 [2]
Links:
[1] http://baltimore.bizjournals.com/baltimore/stories/2008/04/28/story1.html?b=1209355200^1625363
[2] http://www.fiercebiotech.com/special-reports/top-five-regions-targeting-biotech-companies-2008-0